These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32995261)

  • 1. Methylprednisolone pulse therapy: An alternative management of severe COVID-19.
    Sauñe PM; Bryce-Alberti M; Portmann-Baracco AS; Accinelli RA
    Respir Med Case Rep; 2020; 31():101221. PubMed ID: 32995261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of effective intravenous methylprednisolone pulse therapy against severe COVID-19 infection after arteriovenous graft surgery.
    Kamata S; Hamanaka S; Tsukamoto J; Tsuchimoto T; Fujiwara K; Okamura M
    Respirol Case Rep; 2022 Jan; 10(1):e0889. PubMed ID: 34976399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of early low-dose methylprednisolone with long-term treatment in ARDS.
    Hu H; Wei S; Huang J; Sharma L; Chang D
    Eur J Intern Med; 2024 Jun; ():. PubMed ID: 38879352
    [No Abstract]   [Full Text] [Related]  

  • 4. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
    Monreal E; Sainz de la Maza S; Natera-Villalba E; Beltrán-Corbellini Á; Rodríguez-Jorge F; Fernández-Velasco JI; Walo-Delgado P; Muriel A; Zamora J; Alonso-Canovas A; Fortún J; Manzano L; Montero-Errasquín B; Costa-Frossard L; Masjuan J; Villar LM;
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):761-769. PubMed ID: 33083917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
    Fu HY; Luo Y; Gao JP; Wang L; Li HJ; Li X; Xue L; Tang XQ; Li HW; Du YR
    Biomed Res Int; 2020; 2020():2854186. PubMed ID: 33015160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020).
    Bai C; Chotirmall SH; Rello J; Alba GA; Ginns LC; Krishnan JA; Rogers R; Bendstrup E; Burgel PR; Chalmers JD; Chua A; Crothers KA; Duggal A; Kim YW; Laffey JG; Luna CM; Niederman MS; Raghu G; Ramirez JA; Riera J; Roca O; Tamae-Kakazu M; Torres A; Watkins RR; Barrecheguren M; Belliato M; Chami HA; Chen R; Cortes-Puentes GA; Delacruz C; Hayes MM; Heunks LMA; Holets SR; Hough CL; Jagpal S; Jeon K; Johkoh T; Lee MM; Liebler J; McElvaney GN; Moskowitz A; Oeckler RA; Ojanguren I; O'Regan A; Pletz MW; Rhee CK; Schultz MJ; Storti E; Strange C; Thomson CC; Torriani FJ; Wang X; Wuyts W; Xu T; Yang D; Zhang Z; Wilson KC
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33020069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients.
    Lammers AJJ; Brohet RM; Theunissen REP; Koster C; Rood R; Verhagen DWM; Brinkman K; Hassing RJ; Dofferhoff A; El Moussaoui R; Hermanides G; Ellerbroek J; Bokhizzou N; Visser H; van den Berge M; Bax H; Postma DF; Groeneveld PHP
    Int J Infect Dis; 2020 Dec; 101():283-289. PubMed ID: 33007454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with methyl-prednisolone pulses for the late phase of COVID-19 with respiratory failure: A single-center case series.
    Tamura K; Nishioka S; Tamura N; Saito Z; Kuwano K
    Respir Med Case Rep; 2020; 31():101318. PubMed ID: 33318924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.
    Papamanoli A; Yoo J; Grewal P; Predun W; Hotelling J; Jacob R; Mojahedi A; Skopicki HA; Mansour M; Marcos LA; Kalogeropoulos AP
    Eur J Clin Invest; 2021 Feb; 51(2):e13458. PubMed ID: 33219551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease.
    Fatima SA; Asif M; Khan KA; Siddique N; Khan AZ
    Ann Med Surg (Lond); 2020 Dec; 60():413-416. PubMed ID: 33200031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of persons with coronavirus disease 2019 in hospitals with and without standard treatment with (hydroxy)chloroquine.
    Peters EJ; Collard D; Van Assen S; Beudel M; Bomers MK; Buijs J; De Haan LR; De Ruijter W; Douma RA; Elbers PW; Goorhuis A; Gritters van den Oever NC; Knarren LG; Moeniralam HS; Mostard RL; Quanjel MJ; Reidinga AC; Renckens R; Van Den Bergh JP; Vlasveld IN; Sikkens JJ;
    Clin Microbiol Infect; 2021 Feb; 27(2):264-268. PubMed ID: 33068758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral facial nerve palsy associated with COVID-19 and Epstein-Barr virus co-infection.
    Cabrera Muras A; Carmona-Abellán MM; Collía Fernández A; Uterga Valiente JM; Antón Méndez L; García-Moncó JC
    Eur J Neurol; 2021 Jan; 28(1):358-360. PubMed ID: 32997868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.
    Ayerbe L; Risco-Risco C; Ayis S
    Intern Emerg Med; 2020 Nov; 15(8):1501-1506. PubMed ID: 32997237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa.
    Jo Y; Jamieson L; Edoka I; Long L; Silal S; Pulliam JRC; Moultrie H; Sanne I; Meyer-Rath G; Nichols BE
    medRxiv; 2020 Sep; ():. PubMed ID: 32995824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
    Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
    Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between high-dose steroid therapy, respiratory function, and time to discharge in patients with COVID-19: Cohort study.
    Rodríguez-Molinero A; Pérez-López C; Gálvez-Barrón C; Miñarro A; Rodríguez Gullello EA; Collado Pérez I; Milà Ràfols N; Mónaco EE; Hidalgo García A; Añaños Carrasco G; Chamero Pastilla A;
    Med Clin (Barc); 2021 Jan; 156(1):7-12. PubMed ID: 33129511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused.
    Chaudhary S; Natt B; Bime C; Knox KS; Glassberg MK
    Front Med (Lausanne); 2020; 7():539. PubMed ID: 33072773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conspiracy Beliefs, Rejection of Vaccination, and Support for hydroxychloroquine: A Conceptual Replication-Extension in the COVID-19 Pandemic Context.
    Bertin P; Nera K; Delouvée S
    Front Psychol; 2020; 11():565128. PubMed ID: 33071892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome.
    Rubsamen R; Burkholz S; Massey C; Brasel T; Hodge T; Wang L; Herst C; Carback R; Harris P
    Front Pharmacol; 2020; 11():574703. PubMed ID: 33071786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.